Home › Funds › 12 West Capital Management LP › MRVI

12 West Capital Management LP position in MRVI

MARAVAI LIFESCIENCES HLDGS I · Health Care

12 West Capital Management LP reported holding 3,800,069 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q3 2026 13F filing — a position valued at US$29.1M, representing 5.53% of its reported portfolio and ranking #9 among its reported holdings. 12 West Capital Management LP has disclosed MRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.80M sh
Reported value held$29.11M
Portfolio Weight5.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How 12 West Capital Management LP's MRVI position evolved

12 West Capital Management LP first disclosed a stake in MRVI in Q3 2023 at 6,463,111 shares (US$64.6M). The position peaked in Q3 2024 at 14,011,179 shares, worth US$116.4M. Across 13 filings, 12 West Capital Management LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 3,800,069 shares valued at US$29.1M — a reduction of -3,260,126 shares quarter over quarter.. Notable position changes include a 80% increase in Q4 2023 (shares rose 32% over the following quarter), a 29% trim in Q4 2025 (shares fell 13% over the following quarter), a 46% trim in Q3 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.46M $64.63M New
Q4 2023 11.60M $76.00M Add
Q1 2024 13.20M $114.47M Add
Q2 2024 13.21M $94.59M Hold
Q3 2024 14.01M $116.43M Add
Q4 2024 11.59M $63.17M Reduce
Q1 2025 12.52M $27.67M Add
Q2 2025 12.52M $30.18M Hold
Q3 2025 12.52M $35.94M Hold
Q4 2025 8.92M $28.99M Reduce
Q1 2026 7.26M $20.55M Reduce
Q2 2026 7.06M $44.06M Reduce
Q3 2026 3.80M $29.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRVI and 13F data

MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 38 other funds we track also report a position in MRVI — the largest reported positions include GTCR LLC (US$154.3M), BRAIDWELL LP (US$54.3M), GENERAL AMERICAN INVESTORS CO INC (US$13.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRVI

All MRVI fund holders →

FAQ

How long has 12 West Capital Management LP held MRVI?

12 West Capital Management LP has disclosed MRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is 12 West Capital Management LP's current position in MRVI?

As of Q3 2026, 12 West Capital Management LP holds 3.80M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $29.11M, representing 5.53% of its reported portfolio and ranking #9.

Has 12 West Capital Management LP been buying or selling MRVI?

In the latest 13F filing (Q3 2026), 12 West Capital Management LP reduced its position in MRVI. The position peaked in Q3 2024 at 14.01M shares.

Which other funds hold MRVI?

Other major institutional holders of MRVI include GTCR LLC, BRAIDWELL LP, GENERAL AMERICAN INVESTORS CO INC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.